NBIX
Neurocrine Biosciences, Inc.

3,242
Mkt Cap
$13.03B
Volume
947,832.00
52W High
$160.18
52W Low
$84.23
PE Ratio
27.81
NBIX Fundamentals
Price
$129.78
Prev Close
$127.78
Open
$128.64
50D MA
$133.59
Beta
0.76
Avg. Volume
1.34M
EPS (Annual)
$4.67
P/B
3.99
Rev/Employee
$1.43M
$13,528.48
Loading...
Loading...
News
all
press releases
Swiss National Bank Sells 14,100 Shares of Neurocrine Biosciences, Inc. $NBIX
Swiss National Bank reduced its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 4.7% in the 3rd quarter, according to its most recent Form 13F filing with the...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Connor Clark & Lunn Investment Management Ltd. Acquires 32,480 Shares of Neurocrine Biosciences, Inc. $NBIX
Connor Clark & Lunn Investment Management Ltd. grew its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 13.1% in the 3rd quarter, according to the company in its most recent...
MarketBeat·2d ago
News Placeholder
Neurocrine Biosciences (NASDAQ:NBIX) Given New $177.00 Price Target at JPMorgan Chase & Co.
JPMorgan Chase & Co. lifted their target price on shares of Neurocrine Biosciences from $176.00 to $177.00 and gave the company an "overweight" rating in a research note on Thursday...
MarketBeat·2d ago
News Placeholder
Magnetar Financial LLC Acquires New Holdings in Neurocrine Biosciences, Inc. $NBIX
Magnetar Financial LLC acquired a new position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the...
MarketBeat·3d ago
News Placeholder
Korea Investment CORP Has $10.06 Million Stock Holdings in Neurocrine Biosciences, Inc. $NBIX
Korea Investment CORP boosted its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 94.3% in the 3rd quarter, according to the company in its most recent 13F filing...
MarketBeat·3d ago
News Placeholder
First Trust Advisors LP Has $50.97 Million Stock Holdings in Neurocrine Biosciences, Inc. $NBIX
First Trust Advisors LP trimmed its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 14.3% during the third quarter, according to its most recent disclosure with the Securities...
MarketBeat·3d ago
News Placeholder
Capital Fund Management S.A. Has $17.37 Million Holdings in Neurocrine Biosciences, Inc. $NBIX
Capital Fund Management S.A. reduced its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 39.3% in the 3rd quarter, according to the company in its most recent disclosure with...
MarketBeat·3d ago
News Placeholder
Neurocrine Biosciences to Present at the Stifel 2026 Virtual CNS Forum
Neurocrine Biosciences to Present at the Stifel 2026 Virtual CNS Forum Neurocrine Biosciences to Present at the Stifel 2026 Virtual CNS Forum PR Newswire SAN DIEGO, March 10, 2026 SAN DIEGO, March...
PR Newswire·4d ago
News Placeholder
American Century Companies Inc. Sells 52,349 Shares of Neurocrine Biosciences, Inc. $NBIX
American Century Companies Inc. cut its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 27.4% in the third quarter, according to the company in its most recent disclosure with...
MarketBeat·5d ago
News Placeholder
14,653 Shares in Neurocrine Biosciences, Inc. $NBIX Acquired by Munich Reinsurance Co Stock Corp in Munich
Munich Reinsurance Co Stock Corp in Munich acquired a new stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) during the 3rd quarter, according to the company in its most recent filing...
MarketBeat·6d ago
<
1
2
...
>

Latest NBIX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.